GNEミオパチーの治療法開発

DOI

書誌事項

タイトル別名
  • Sialic acid supplementation therapy for GNE myopathy

この論文をさがす

説明

<p>GNE myopathy is rare muscle disease affecting distal muscles like tibialis anterior. GNE gene, which encodes for a key enzyme in the sialic acid biosynthesis pathway, is mutated in the homozygote or compound heterozygote manner. The lack of sialic acid in skeletal muscle is the critical pathological process in GNE myopathy. GNE myopathy mouse model was established and supplementation of sialic acid improves the phenotype of these models. Phase 1 clinical trial in Japan was conducted at Tohoku University Hospital using aceneuramic acid, followed by the trials using slow release product of sialic acid. Phase II/III study was performed.</p>

収録刊行物

  • 神経治療学

    神経治療学 37 (4), 656-660, 2020

    日本神経治療学会

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ